
Pfizer appoints Cecile Guegan as its chief financial officer
Guegan has been interim CFO since 16 Aug 2026. Her annual base salary is $1.3 million, with a target cash incentive of the same amount.
- US stocks
- Management change
NYSE: PFEPfizer
Every Pfizer filing with the US SEC that Blacklitt has written about, explained in plain words and linked to the filing, newest first: earnings, management change.
2 articles · Health Care · Latest 4 Nov 2026

Guegan has been interim CFO since 16 Aug 2026. Her annual base salary is $1.3 million, with a target cash incentive of the same amount.

Pfizer (NYSE: PFE) reported GAAP revenue of $16.6 billion and GAAP net income of $3.24 billion for the third quarter of 2026, and it said on 3 Nov 2026. GAAP diluted EPS was $0.56, and adjusted diluted EPS, a company-defined measure, was $0.87.